Effective management of recurrent Doege–Potter syndrome with somatostatin‐analogues: A case report

Effective management of recurrent Doege–Potter syndrome with somatostatin‐analogues: A case report

Abstract Background Doege–Potter syndrome is defined as paraneoplastic hypoinsulinemic hypoglycemia associated with a benign or malignant solitary fibrous tumor frequently located in pleural, but also extrapleural sites. Hypoglycemia can be attributed to paraneoplastic secretion of “Big‐IGF‐II,” a p...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Felix Schöler, Maximilian Andreas Storz, Ashkan Khavaran, Nicolas Hümmler, Maximilian Frederik Russe, Christoph‐Ferdinand Wielenberg, Katharina Laubner, Jochen Seufert
التنسيق: مقال
اللغة:English
منشور في: Wiley 2024-03-01
سلاسل:Cancer Reports
الموضوعات:
debulking surgery
Doege–Potter syndrome
insulin‐like growth factor II
Lanreotide
Octreotide
solitary fibrous tumor
الوصول للمادة أونلاين:https://doi.org/10.1002/cnr2.1992

الانترنت

https://doi.org/10.1002/cnr2.1992

مواد مشابهة